| Date | Agency | What | Amount |
|---|---|---|---|
| Sep 30, 2026 | National Institutes of Health | Therapeutic testing in murine models of bacterial infection record | $546K |
| Jul 22, 2026 | National Institutes of Health | Mouse model of neisseria gonorrhoeae infection record | $621K |
| Jul 15, 2024 | National Institutes of Health | A12 - murine models of uti infection caused by antibiotic-resistant bacteria record | $169K |
| Jul 12, 2024 | National Institutes of Health | Mouse model of neisseria gonorrhoeae infection record | $331K |
| Jul 10, 2024 | National Institutes of Health | A94 - testing in murine models of bacterial infection record | $503K |
| Aug 31, 2023 | National Institutes of Health | Pre-clinical models of infectious disease record | $1.2M |
| Jul 19, 2023 | National Institutes of Health | Murine models of uti infection caused by antibiotic-resistant bacteria record | $599K |
| Aug 12, 2022 | National Institutes of Health | Pcmid idiq record | $1.2M |
| May 16, 2022 | National Institutes of Health | Pcmid task area a67 record | $289K |
| Sep 7, 2021 | National Institutes of Health | Preclinical models of infectious diseases record | $681K |
| 541714 | Research and development in biotechnology (except nanobiotechnology) | $1.3M |
| 541711 | Research and development in biotechnology | $1.2M |
Claim this free profile and we'll email you new government bids like the ones you already win (NAICS 541714, 541711), every morning.
Claim this profile — freeSource: USAspending.gov public federal contract records (contracts only, last 3 years; amounts are obligations). Updated Nov 9, 2026. BidsNexus is not affiliated with this company.